Table 2.
Variable | DAS28 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Male |
Female |
|||||||||||
Unadjusted β | SE | p | Adjusted β | SE | p value | Unadjusted β | SE | p value | Adjusted β | SE | p value | |
Age | 0.002 | 0.012 | 0.889 | NA | 0.015 | 0.006 | 0.009 | |||||
Disease duration, yr | 0.017 | 0.031 | 0.587 | NA | 0.024 | 0.011 | 0.032 | |||||
Anti-CCP | 0.471 | 0.337 | 0.169 | NA | –0.191 | 0.155 | 0.218 | |||||
Current steroid dose | 0.248 | 0.106 | 0.024 | NA | 0.163 | 0.051 | 0.002 | 0.118 | 0.049 | 0.017 | ||
BMI | –0.049 | 0.040 | 0.226 | NA | 0.061 | 0.018 | 0.001 | a | ||||
Body fat mass | –0.033 | 0.220 | 0.136 | NA | 0.034 | 0.008 | < 0.001 | 0.022 | 0.010 | 0.024 | ||
Skeletal muscle mass | –0.019 | 0.030 | 0.519 | NA | –0.034 | 0.025 | 0.170 | |||||
Body fat/skeletal muscle ratio | 0.228 | 0.203 | 0.268 | NA | 0.184 | 0.199 | 0.356 | |||||
HAQ | 0.881 | 0.457 | 0.060 | NA | 1.006 | 0.111 | < 0.001 | 0.858 | 0.127 | < 0.001 |
DAS28, disease activity score in 28 joints; SE, standard error; NA, not applicable; CCP, citrullinated protein antibody; BMI, body mass index; HAQ, health assessment questionnaire.
Body mass index was excluded from multivariable analysis due to collinearity problems with fat mass.